FindTrial
Sign In

A Study For Effect Of The Homoeopathic Medicine Medorrhinum In The Treatment Of Chronic Allergic Rhinitis

To Study The Role Of Medorrhinum In Chronic Allergic Rhinitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106002
Enrollment
30
Registered
2026-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J30- Vasomotor and allergic rhinitis

Interventions

Intervention1: Medorrhinum: Medorrhinum Dose As Per Requirement Of Case Administration within time duration of 9 months Control Intervention1: NIL: NIL

Sponsors

C D Pachchigar College Of Homoeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 10 To 60 Years Both Gender Diagnosed Cases Of Allergic Rhinitis Presence Of Key Indications Of Medorrhinum (Example Better At Night, Oversensitive to Smell, Chronic Nasal Blockage, Hereditary History Cases Where Patient Is On Long Term Antihisamines Or Steroids

Exclusion criteria

Exclusion criteria: Cases Requiring Emergency Management Or Complicated By Asthma Structural Nasal Defect Like Deviated Nasal Septum Disease like Nasal Polyp, Adenoid Etc.

Design outcomes

Primary

MeasureTime frame
To Evaluate The Symptom Relief In Chronic Allergic Rhinitis Using Medorrhinum.Timepoint: 9 Months—

Secondary

MeasureTime frame
Measurement Of Changes In Symptoms Severity In Cases Of Chronic Allergic Rhinitis Using Total Nasal Symptom Score As An Assessment ToolTimepoint: 9 Months—

Countries

India

Contacts

Public ContactSoni Rohan Shyamkumar

C D Pachchigar College Of Homoeopathic Medicine And Hospital

doctormanishvadan@yahoo.co.in9998667227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026